Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
43.00+0.01 (+0.02%)
At close: 4:00PM EDT
43.00 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close42.99
Open42.93
Bid42.50 x 800
Ask45.00 x 1100
Day's Range42.33 - 44.43
52 Week Range27.87 - 60.67
Volume290,942
Avg. Volume431,533
Market Cap1.45B
Beta (5Y Monthly)1.49
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.14
  • Benzinga

    Notable Biolife Solutions Insider Trades $860K In Company Stock

    Aby Mathew, EVP And Chief Scientific Officer at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on October 20, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on October 20. They then sold their shares on succeeding transactions in the open market. They sold at prices r

  • Motley Fool

    Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom

    One unsung hero in the effort is a small company helping facilitate the production of cell and gene therapies called BioLife Solutions (NASDAQ: BLFS). It creates, builds, and sells tools for bioproduction to the cell and gene therapy (CGT) industry.

  • Benzinga

    Biolife Solutions Insider Trades $130K In Company Stock

    Joseph C Schick, Director at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Schick sold 3,250 shares of Biolife Solutions at prices ranging from $39.96 to $40.28. The total transaction amounted to $130,145. Following the transaction, Schick still owns 8,625 shares of the company, worth $335,253. Biolife Solutions shares are trading up 1.

Advertisement
Advertisement